I00-I99 M00-M99
Conditions
Interventions
Group 1: All patients are first screened with the PHQ-9 (Spritzer et al. 1999). We then use the Columbia Suicide Severity Rating Scale (C-SSRD
Posner et al. 2011) as a reference standard to determine suicidality. All patients who report either a score > 0 for item 9 of the PHQ-9 (thoughts that you would be better off dead or of hurting yours
Sponsors
Universität zu Lübeck, Institut für Sozialmedizin und Epidemiologie
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: We include patients aged 18 to 70 years with cardiovascular disease or musculoskeletal disorders and recruit them consecutively in equal numbers (200 patients each).
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Our study tests the diagnostic accuracy (sensitivity and specificity) of item 9 of the PHQ-9 and the total score of the PHQ-9 (Spritzer et al. 1999) for identifying suicidality. We use the C-SSRS (Posner et al. 2011) as the reference standard for the presence of suicidality. The C-SSRS is a standardized interview and is administered to the patient by trained staff. All study participants will be initially screened with the PHQ-9 at the beginning of rehabilitation. Subsequently, regardless of the screening result and without knowledge of this result, suicidality will be assessed with the C-SSRS. A positive score on the C-SSRS is defined as suicidal ideation with intent to act or recent suicidal behavior. Cutoffs for possible suicidality are defined as a score > 0 for item 9 of the PHQ-9 and a score > 14 for the total score of the PHQ-9. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the suicide prevention concept implemented in the rehabilitation facility, we record, among other things, the completeness of the intervention provided, patients’ perception of the intervention, and the number of people reached. To describe the sample, we also record age, gender, education, partnership, treatment diagnosis and comorbidity, and somatization and anxiety (Spritzer et al. 1999). | — |
Countries
Germany
Contacts
Public ContactMatthias Bethge
Universität zu Lübeck, Institut für Sozialmedizin und Epidemiologie
Outcome results
None listed